AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Depravan ER 37.5 Tablet

Prescription Icon
Prescription Required

Marketer

Matias Healthcare Pvt Ltd

Salt Composition

Venlafaxine (37.5mg)

Overview Depravan ER 37.5 Tablet

Anxiolin ER 37.5mg tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating symptoms like agitation, edginess, poor concentration, lethargy, perspiration, tachycardia, and racing thoughts. Take Anxiolin ER 37.5mg with food, consistently at the same time daily for optimal blood levels. Missed doses should be taken upon recall; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt cessation is discouraged as it could exacerbate symptoms. Possible side effects, typically transient, include nausea, vomiting, sleep disturbances, reduced appetite, anxiety, bowel irregularity, hyperhidrosis, and sexual difficulties. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until effects are known. Persistent or bothersome side effects warrant medical attention. Prior to commencing Anxiolin ER 37.5mg therapy, disclose any kidney, heart, or liver conditions, or a history of seizures to your physician. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation immediately.

Uses of Depravan ER 37.5 Tablet

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Depravan ER 37.5 Tablet:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Ingest Depravan ER 37.5 Tablet with a meal.

Common Side effects of Depravan ER 37.5 Tablet:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Depravan ER 37.5 Tablet:

Follow your physician's instructions or consult the product labeling for proper administration. Ingest Depravan ER 37.5 Tablet with a meal.

How Depravan ER 37.5 Tablet works:

Depravan ER 37.5 mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Depravan ER 37.5 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Depravan ER 37.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Depravan 37.5 mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and healthy weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Depravan ER 37.5 Tablet side effects. These side effects can include dizziness, confusion, and visual disturbances like blurred vision, all of which could negatively impact driving skills.

KidneyKidneyCAUTION

Exercise caution when administering Depravan ER 37.5mg tablets to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Depravan ER 37.5mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

What if you forget to take Depravan ER 37.5 Tablet :

Should you forget to take your Depravan ER 37.5mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Depravan ER 37.5 Tablet

LabelValue
Chemical Category Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Actions SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Depravan ER 37.5 Tablet

Depravan ER 37.5mg tablets can cause drowsiness. Inform your doctor about any other sleep aids you're using before taking this medication.
Yes. Depravan ER 37.5 mg tablets are psychotropic medications; these drugs affect mental function, mood, and behavior.
No, Depravan ER 37.5 mg tablets are not narcotics. Narcotics are opioid derivatives, such as heroin and morphine, known for their sedative effects.
Depravan ER 37.5 tablets, whether ER or XR, are the same extended-release medication. This formulation provides slow, sustained drug release, maintaining consistent therapeutic levels. Extended-release tablets reduce the frequency of dosing.
Taking mirtazapine with Depravan ER 37.5mg tablets can cause a serious, potentially life-threatening side effect: serotonin syndrome. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Depravan ER 37.5mg tablets elevates serotonin levels, risking serotonin syndrome. This potentially fatal condition manifests as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma. An alternative medication should be considered.
P-glycoprotein pumps Depravan ER 37.5 Tablet out of the brain. However, some research indicates that Depravan ER 37.5 Tablet and its metabolite can inhibit this pump.
Depravan ER 37.5 mg tablets are absorbed in the intestines following hepatic metabolism.
Depravan ER 37.5mg tablets treat generalized depression. Always consult a doctor before use.
Treatment with Depravan ER 37.5 Tablets may cause a sustained rise in blood pressure in some individuals. Regular blood pressure monitoring is recommended for patients taking Depravan ER 37.5 Tablets; dose adjustment or treatment discontinuation may be necessary.
Constipation is a known side effect of Depravan ER 37.5 mg tablets. Increase fiber and water intake; laxatives may also help. Your doctor can advise on prevention and management. Consult your doctor if constipation persists or worsens.
Yes, Depravan ER 37.5 mg tablets have been associated with weight loss in some patients. Studies show this weight loss increases with higher doses and longer treatment durations. Talk to your doctor if this is concerning.
Depravan ER 37.5 mg tablets are not habit-forming.
Consult your doctor before substituting tablets for capsules. Altering your medication without professional guidance is unsafe, as differing formulations affect drug release and may result in treatment failure or adverse effects.
Gabapentin may be used concurrently with Depravan ER 37.5 mg tablets, but only under a physician's supervision. Combined use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Depravan ER 37.5 Tablet.
Depravan ER 37.5 mg tablets are not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia.
While not FDA-approved for nerve pain, Depravan ER 37.5 mg tablets have shown efficacy in some research studies and are used off-label for this purpose.
Depravan ER 37.5 mg tablets can alter brain neurotransmitter levels, resulting in reduced appetite. This appetite suppression is dose-related.
Experience decreased sex drive or impotence? Consult your doctor; alternative medications may be available. Do not discontinue Depravan ER 37.5 Tablet without medical supervision; doing so may worsen side effects.
Depravan ER 37.5 Tablet
39
MRP 45
13% off